MISSION
To bring scientists, executives and other biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the biotechnology/pharmaceutical world, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.
BioPacific Conference 2016 (aka 18th Annual Conference of CABS, Chinese- American BioPharmaceutical Society), will be held on May 7th, 2016 in the San Francisco Bay Area at San Mateo Marriott, 1770 South Amphlett Blvd., San Mateo, CA. This full-day event is expected to attract over 400 attendees of life science professionals from the great San Francisco Bay Area.
Date and Time:May 7th, Saturday, 2016, 8:00AM-9:00PM
Location: San Mateo Marriott, 1770 South Amphlett Blvd., San Mateo, CA 94402
The theme of the BioPacific Conference 2016 will be “Shooting for the Stars – Entering the Dawn of Unprecedented Breakthroughs in Life Sciences & Medicine”.
Our meeting will showcase:
- Winner of 2016 CABS K. Fong Award in Life Sciences
- Success stories of entrepreneurs and emerging companies including Adheron Therapeutics and PaxVax
- Most promising areas in life sciences including cancer immunotherapy, big data in the genome era and CRISPR/dCas9 technology
- Biopharmaceutical Development – China & Global Considerations
- US-China Cross-Border Healthcare Investment & Entrepreneurship
- Two-day BioPacific Forum to facilitate interactions including project introduction and talent recruitment between attendees and sponsors
|
Confirmed Speakers
|
|
|---|---|
 |
Dr. Gerald Chan Co-founder Morningside Group |
 |
Dr. Jennifer Hu Venture Partner Qiming Venture Partners US |
 |
Dr. Connie Sun Senior Vice President of Business & Corporate Development Pharmaron |
 |
Mr. Hui Zhang (张辉) Deputy Director, Investment and Partnership Branch (投资合作局副局长) Ningbo Hangzhou Bay New Zone (宁波杭州湾新区) |
 |
Mr. Robert Lou (楼国强) Manager Director (总经理) Ningbo Kangtaibo Technology Development Co.,Ltd（宁波康泰博科技发展有限公司） |
 |
Dr. Darren Ji Vice President and Global Head Roche Partnering Asia and Emerging Markets |
 |
Dr. Hari Kumar Ex CEO and BOD Adheron Therapeutics Inc. |
 |
Mr. Piers Whitehead Executive Vice President & Chief Business Officer PaxVax |
 |
Dr. Mark Selby Senior Director of Immuno-Oncology Bristol-Myers Squibb |
 |
Dr. Stanley Lei Qi Assistant Professor in the Department of Bioengineering, and of Chemical and Systems Biology and faculty fellow in the interdisciplinary Institute for Chemistry, Engineering, and Medicine for Human Health (ChEM-H) Stanford University |
 |
Mr. Tom L. Irving Partner Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
 |
Dr. Shawn Qian Co-Founder, President & CEO NeuPharma |
 |
Dr. Wen Li Associate Finnegan, Henderson, Farabow, Garrett & Dunner, LLP |
 |
Dr. Xian-Ping Lu Chief Executive Officer & Chief Scientific Officer Chipscreen Biosciences Ltd |
 |
Dr. Dan Zhang Chairman and CEO Fountain Medical Development Ltd |
 |
Dr. Alexis Ji Ph.D., MBA, Principal WuXi Healthcare Ventures |
 |
Dr. James Zhao Founding Partner LYFE Capital |
 |
Ms. Yuwen Liu Founding Partner Bohe Angel Fund |
 |
Dr. Min Cui Founding Partner and Managing Director Decheng Capital |
 |
Dr. Vincent Liu Senior Consultant Wanbang Biopharmaceutical Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
 |
Dr. Shawn Lee Vice-Chairman Xinbang Pharmaceutical |
 |
Dr. Cheng Liu Founder and CEO Eureka Therapeutics |
 |
Mr. Jinqun Yin MBA, Vice President Chengdu Kanghong Pharmaceutical Group Co., Ltd |
 |
Dr. Xiaodong Yang President and Chief Executive Officer Apexigen |
 |
Mr. Charles Comey Partner Morrison & Foerster |
 |
Dr. Cheni Kwok Senior Consultant Shanghai Medicilon |
